Transcription of Shelf-Life Determination - IICAB Presentation
{{id}} {{{paragraph}}}
Pharmaceutical shelf life Determination :Findings of the PQRI stability shelf life Working GroupJames Schwenke, StatisticianApplied Research Consultants, LLCD etermining Release and Throughout Dating Potency Specifications:A Regulatory Policy WorkshopApril 21 22, 2015 Product Quality Research Institute (PQRI) stability shelf life Working Group PERSPECTIVE The Working Group is comprised of members from the R&D pharmaceutical industry including Statisticians, CMC and regulatory affairs as well as academia and FDA. The Working Group has been together since 2006 with a core of original members. Past members still keep in touch, with new members being added, together contributing a variety of experiences, opinions and philosophies. The statistical issues presented and discussed throughout this Presentation are not dependent on species, product type or formulation.
ICH/FDA Guidance • ICH Guideline Q1E defines shelf life as “The shelf life of a pharmaceutical product is the maximum time at which the true mean response of a stability limiting
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Q 1 A, Stability Testing of new Drug, STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS, Guideline, ICH Q1A guideline, ICH Q1A(R2) Guideline Stability Testing of New, International conference on harmonisation, Guideline stability testing of new, STABILITY TESTING OF NEW, Long Term Stability Testing Conditions:, Long Term Stability Testing Conditions: Position, Stability Workshop ICH Q1F C, Guideline Stability, STABILITY TESTING, PHARMACEUTICAL, PHARMACEUTICAL INGREDIENTS AND, FINISHED PHARMACEUTICAL PRODUCTS, Q10 Questions and Answers, ICH guideline, Q10 - questions and answers, IMPURITIES IN EW DRUG SUBSTANCES